scholarly journals Can Our Blood Groups Determine Our Life Expectancy?

2021 ◽  
Author(s):  
Gülçin Şahingöz Erdal ◽  
İsmail Bıyık ◽  
Pınar Kasapoğlu ◽  
Muhammet Hulusi Satılmışoğlu ◽  
Nlgün Işıksaçan
Keyword(s):  
Acute Coronary Syndrome ◽  
Blood Group ◽  
Blood Groups ◽  
Term Survival ◽  
Coronary Syndrome ◽  
Study Results ◽  
Significant Difference ◽  
Balanced Distribution ◽  
Tertiary Hospitals

Background/aim: In this study, we aimed to investigate the relationship between long-term mortality and survival with ABO blood group in patients with acute coronary syndrome. Materials and methods: This observational study was carried out in two tertiary hospitals. 192 patients followed for 72 months due to acute coronary syndrome, showing a balanced distribution for ejection fraction, additional diseases and age, were included in the study. Results: The survival rate was evaluated in 72 months follow-up. In the survival analysis according to individual blood groups; there was no statistically significant difference between the groups. When the patients were divided into two groups, there was 24.39% mortality in those with O blood group and 15.23% mortality in those without O blood group (p>0.05). Although it was not statistically significant, in patients with O blood group, an increasing tendency was observed in 72 month mortality (p>0.05). There was no association between Rh antigen and survival in this study (p=0.79). Conclusion: Although it was not able to reach statistically significance limit, a decreasing tendency in long-term survival was observed in patients with O blood group compared to those without O blood group in patients with acute coronary syndrome. The results should be confirmed by larger prospective studies.

scholarly journals Predictors for Long-Term Prognosis after Acute Coronary Syndrome

2021 ◽  
Vol 14 (1) ◽  
pp. 31-46
Author(s):  
Krastina I. Doneva-Basheva ◽  
Damyan P. Petrov ◽  
Tatyana I. Vlaykova ◽  
Snezhana T. Tisheva
Keyword(s):  
Acute Coronary Syndrome ◽  
Regression Analysis ◽  
Systolic Function ◽  
Developed Countries ◽  
Elderly Age ◽  
Term Survival ◽  
Coronary Syndrome ◽  
Significant Difference ◽  
Grace Score

Summary Cardiovascular diseases (CVD) are the leading cause of invalidity and death in developed countries. Among them, the main cause of death is coronary artery disease. In this retrospective study, 172 patients with acute coronary syndrome (STEMI, NSTEMI, UA) are included. They had been hospitalized on an emergency basis in the Cardiology Department, Invasive Sector of Prof. Dr. St. Kirkovich Hospital in Stara Zagora, and the Cardiology Hospital -Yambol between January 2009 and February 2010. We found a significant difference in the age at acute coronary syndrome (ACS) occurrence by sex: earlier manifestation was observed in men (p=0.018). The univariant regression analysis showed that elderly age (p=0.005, OR 1.024), glomerular filtration <90 ml/h (p=0.006, OR 0.964), GRACE-score > 140 pt (p<0.001, OR 1.045), HF (Killip class ≥ II) (p=0.002, OR 15.6) and EF<40% (p=0.003, OR 1) were factors for adverse prognosis in the first, fifth and ninth year. Only GRACE-score was an independent predictor of death obtained by multivariate regression analysis in the study (p=0.002, OR 1.052). The factors influencing long-term survival adversely after ACS are age, smoking, chronic kidney disease, previously experienced myocardial infarction, diabetes mellitus, three-vessel coronary disease, and decreased systolic function of the left ventricle, and GRACE > 140 p.

Successfully Resuscitated Cardiac Arrest is Associated with Reduced In-hospital, but not Long-term Survival in Acute Coronary Syndrome

2008 ◽  
Vol 17 ◽  
pp. S108
Author(s):  
Benjamin K. Dundon ◽  
Luan T. Huynh ◽  
Stephen G. Worthley ◽  
Carolyn Astley ◽  
Ashish Soman ◽  
...  
Keyword(s):  
Acute Coronary Syndrome ◽  
Cardiac Arrest ◽  
Term Survival ◽  
Long Term Survival ◽  
Coronary Syndrome

scholarly journals Long-term survival and causes of death in patients with ST-elevation acute coronary syndrome without obstructive coronary artery disease

2017 ◽  
Vol 39 (2) ◽  
pp. 102-110 ◽  
Author(s):  
Hedvig Bille Andersson ◽  
Frants Pedersen ◽  
Thomas Engstrøm ◽  
Steffen Helqvist ◽  
Morten Kvistholm Jensen ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Acute Coronary Syndrome ◽  
Coronary Artery ◽  
Causes Of Death ◽  
Obstructive Coronary Artery Disease ◽  
Term Survival ◽  
Coronary Syndrome ◽  
St Elevation ◽  
Artery Disease

scholarly journals Implementation and evaluation of the clinical pathway for the diagnosis and treatment of acute coronary syndrome

2018 ◽  
Vol 8 (1) ◽  
pp. 46-53
Author(s):  
Bishnu Mani Dhital ◽  
Ou Yang Mao ◽  
Shyam Raj Regmi ◽  
Sudhir Regmi
Keyword(s):  
Acute Coronary Syndrome ◽  
Clinical Pathway ◽  
Clinical Pathways ◽  
Final Diagnosis ◽  
Developed Countries ◽  
Diagnosis And Treatment ◽  
Coronary Syndrome ◽  
Significant Difference ◽  
Tertiary Hospitals ◽  
Timi Risk Score

Background: The clinical pathways have been developed to guide and standardize diagnosis, treatment of certain diseases, optimize smooth patient care, and its application has been proven to regulate the medical practice and to improve the quality of medical care in developed countries. Objective: To analyze and evaluate the diagnosis and treatment of acute coronary syndrome (ACS) after the implementation of clinical pathways and to identify the areas need to be improved in clinical practice in Xiangya Third Hospital of Central South University. Methods: 250 ACS patients, divided into five groups 50 in each, were collected from December 2009 to December 2011, the first group was considered as baseline and compared with other four group. All these data were compared and analyzed with other tertiary hospitals of china. Results: STEMI patients arriving within 12 hours of onset of symptoms was increased (P<0.05), and final diagnosis consistent with cardiac markers was also increased (P<0.05).Use of aspirin, clopidogrel, β-Blocker, ACEI /ARB, and statin was higher (P>0.05), but the use of clopidogrel and statin was significantly higher (P<0.05) than other hospitals; no significant difference (P>0.05) in Door-to-needle time or Door-to-balloon time, though longer than standard guidelines, but the door-to-needle time was shorter when compared with other hospitals. TIMI risk score of UA/NSTEMI patients and invasive therapy (PCI) was negatively correlated (r = -0.312, P<0.05), and results were similar when compared with other hospitals; high-risk patients increased, but no significant difference in mortality (P>0.05). Conclusion: Implementation of Clinical pathway may help to improve patient outcome with early invasive and medical therapy.

Sign in / Sign up

Export Citation Format

Share Document